Global Insulin Patch Pumps market outlook 2024, Forecast To 2033
2 Feb, 2024
The insulin patch pumps market has experienced rapid growth, escalating from $1.32 billion in 2023 to $1.46 billion in 2024, with a compound annual growth rate (CAGR) of 11.0%. This expansion in the historic period is attributable to the increased prevalence of diabetes, a growing preference for non-invasive delivery methods, a rise in the geriatric population, heightened safety concerns, and advancements in miniaturization and improved form factors. Foreseeing swift growth in the next few years, the market is projected to reach $2.16 billion in 2028, reflecting a CAGR of 10.3%. The anticipated growth is linked to the increasing adoption of telehealth, a surge in pediatric diabetes cases, rising awareness about diabetes, concerns for environmental sustainability, and growing healthcare initiatives. Key trends in the forecast period encompass the incorporation of quantum computing design tools, the integration of artificial intelligence and machine learning, the adoption of digital twin simulations, advancements in custom IC design tools, and the growth in high-level synthesis tools.
Global Insulin Patch Pumps Market Key Driver
The rising global prevalence of diabetes is anticipated to propel the growth of the insulin patch pumps market. Insulin patch pumps offer convenient insulin delivery for people with diabetes. According to the International Diabetes Federation, 537 million people aged 20 to 79 had diabetes in 2021, projected to increase to 643 million by 2030. In 2021, diabetes led to 6.7 million deaths. Therefore, the growing prevalence of diabetes worldwide will drive the insulin patch pumps market.
Get A Free Sample Of The Global Insulin Patch Pumps Market ReportGlobal Insulin Patch Pumps Market Segments
The global insulin patch pumps market covered in this report is segmented –
1) By Type: Traditional Insulin Pumps, Smart Insulin Pump, Disposable Insulin Pumps
2) By Mode: Basal, Bolus
3) By Pump Type: Tethered Pump, Patch Pump
4) By Application: Type 1 Diabetes, Type 2 Diabetes
5) By End-User: Hospital, Clicins, Laboratories, Other End-Users
Major Insulin Patch Pumps Industry Players
Cellnovo Group SA, Insulet Corporation, Medtronic PLC, Tandem Diabetes Care Inc., Hoffmann-La-Roche AG, AMF Medical SA, Animus Corp., Abbott Laboratories Inc., Becton Dickinson and Company, Braun Melsungen AG, Cequr SA, Debiotech SA, DexCom Inc., Eoflow Co. Ltd., Embecta Corp., Hospira Inc., Johnson & Johnson Services Inc., LifeScan Inc., Sanofi S.A., Univlabs Technologies Pvt. Ltd., Ypsomed Holding AG, Zealand Pharma A/S, Bigfoot Biomedical Inc., Echo Therapeutics Inc., Glysens Inc., Medella Health Ltd., Roche Diabetes Care GmbH, Valeritas Inc., 3S Corporation, Apex Medical Devices
Get The Full Global Insulin Patch Pumps Market Report
Insulin Patch Pumps Market Overview
Insulin patch pumps are small, computerized devices with pre-programmed delivery of insulin dosage to a diabetic patient to conveniently manage their blood sugar. An insulin patch pump is often attached to a strap under the garments, in a pocket, on the waist belt, and with an adhesive patch on the stomach or arm of the patient.
Insulin Patch Pumps Global Market Report 2023 provides data on the global insulin patch pumps market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The insulin patch pumps market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.